The ongoing clinical trials of Brain-Computer Interfaces (BCIs) such as Neuralink’s “Telepathy” implant involve establishing communication links between...
Results from the phase2 trial support the view that subcutaneous administration of IFN- β for treatment of COVID-19 enhances speed of recovery and reduces mortality....
Scientists have designed a new chest-laminated, ultrathin, 100 percent stretchable cardiac sensing electronic device (e-tattoo) to monitor heart functions. The device can measure ECG,...
Scientific research has proven that dogs are compassionate beings who overcome obstacles to help their human owners.
Humans have domesticated dogs for thousands of years...
A combination of biological and computational approach to study protein-protein interactions (PPIs) between the viral and the host proteins in order to identify and...
Scientists have discovered a safe and non-addictive synthetic bifunctional drug for relieving pain
Opioids provide the most effective pain relief. However, opioid usage has reached...
On 11 October 2024, Hympavzi (marstacimab-hncq), a human monoclonal antibody targeting “tissue factor pathway inhibitor” received US FDA’s approval as a new drug for...
In June 2020, RECOVERY trial from a group of researchers in Oxford University UK reported use of low-cost dexamethasone1 for treatment of severely ill COVID-19...
Earth’s most detectable techno-signatures are the planetary radar transmissions from the erstwhile Arecibo Observatory. The Arecibo message could be detected up...
For the first time dormant multicellular organisms’ nematodes were revived after being buried in permafrost deposits for thousands of years.
In quite an interesting discovery...